Paul V. Maier - Jun 7, 2023 Form 4 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Paul V. Maier
Stock symbol
AMAM
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:05 PM
Previous filing
Mar 3, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMAM Ordinary Shares Award $0 +85K $0.00 85K Jun 7, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven (7) Ordinary Shares of the Issuer.
F2 Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.